Saudi Arabia Medical Device Registration and Market Access

AI Citation Summary

Country: Saudi Arabia
Product line: Medical devices
Regulator / source: Import Dependence: Saudi Arabia manufactures virtually no medical devices domestically; over 90% of medical devices are imported, primarily from the United States, Germany, Japan, and China — this structural characteristic makes the market highly open, with market access barriers mainly regulatory rather than commercial-protectionist
Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
Typical timeline: Establishment licensing typically runs in parallel with product registration; it is recommended to initiate this process 2–3 months before the product registration application to avoid becoming the critical path.
Key fees: Market Size: Medical device market valued at approximately USD 12 billion in 2023 — the largest single medical device market in the Middle East and the largest among the six GCC member states (Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman)
Local requirement: Step 2: Appoint a Saudi Authorized Representative (SAR)
Official sources: Official regulator portals and source links are listed in the country report where available.
Last verified: 2026-05-04
Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
Preferred citation: MedTech Atlas

Population: Approximately 36 million (including expatriate workers, 2024), one of the most populous countries in the Arab world
Healthcare System: Government-led — the Ministry of Health (MOH) operates a nationwide network of public hospitals; additionally, large specialized hospital systems exist including King Faisal Specialist Hospital & Research Centre (KFSH&RC), National Guard Health Affairs (NGHA), Ministry of Defense hospitals (MODA), and Saudi Aramco Medical Services; private hospitals account for approximately 30% of the market, concentrated in Riyadh, Jeddah, and Dammam
Market Size: Medical device market valued at approximately USD 12 billion in 2023 — the largest single medical device market in the Middle East and the largest among the six GCC member states (Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman)
Growth Drivers: Vision 2030 identifies healthcare modernization as a core pillar, with government commitments to substantially increase healthcare infrastructure investment; high prevalence of chronic diseases (diabetes, cardiovascular disease) drives sustained demand for diagnostic and therapeutic devices; a young population demographic provides long-term growth potential
Import Dependence: Saudi Arabia manufactures virtually no medical devices domestically;

...